The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 12, 2024 | Geraghty James A | Director | Disposed to issuer(D) | 1 | $0.01 | $0 |
| Dec 2, 2024 | Kiritsy Christopher P | Director | Grant(A) | 500 | — | $0 |
| Aug 12, 2024 | ADAR1 Capital Management, LLC | 10% Owner | Buy(P) | 757 | $15.88 | $12K |
| Aug 12, 2024 | ADAR1 Capital Management, LLC | 10% Owner | Buy(P) | 2K | $15.88 | $36K |
| Aug 9, 2024 | ADAR1 Capital Management, LLC | 10% Owner | Buy(P) | 3K | $14.89 | $45K |
| Aug 7, 2024 | Geraghty James A | Director | Buy(P) | 1 | $1.00 | $1 |
| Jun 21, 2023 | Sherman Matthew L | Director | Grant(A) | 40K | — | $0 |
| Jun 21, 2023 | Said Maya R. | Director | Grant(A) | 40K | — | $0 |
| Jun 21, 2023 | Richman Michael | Director | Grant(A) | 40K | — | $0 |
| Jun 21, 2023 | Kiritsy Christopher P | Director | Grant(A) | 40K | — | $0 |
| Jun 21, 2023 | Kiener Peter A | Director | Grant(A) | 40K | — | $0 |
| Jun 21, 2023 | Geraghty James A | Director | Grant(A) | 45K | — | $0 |
| Jun 21, 2023 | Barbier Ann | Director | Grant(A) | 40K | — | $0 |
| May 25, 2023 | Kiritsy Christopher P | Director | Buy(P) | 10K | $0.85 | $9K |
| Feb 24, 2023 | Yoder Stephen S. | Chief Executive Officer, Director | Grant(A) | 634K | — | $0 |
| Feb 24, 2023 | Olwill Shane | Chief Development Officer | Grant(A) | 249K | — | $0 |
| Feb 24, 2023 | Mousa Ahmed | Chief Business Officer | Grant(A) | 249K | — | $0 |
| Feb 24, 2023 | Kaufmann Hitto | Chief Scientific Officer | Grant(A) | 249K | — | $0 |
| Feb 24, 2023 | Bures Thomas | Chief Financial Officer | Grant(A) | 249K | — | $0 |
| Jun 22, 2022 | Barbier Ann | Director | Grant(A) | 40K | — | $0 |
| Jun 22, 2022 | Said Maya R. | Director | Grant(A) | 40K | — | $0 |
| Jun 22, 2022 | Geraghty James A | Director | Grant(A) | 45K | — | $0 |
| Jun 22, 2022 | Kiener Peter A | Director | Grant(A) | 40K | — | $0 |
| Jun 22, 2022 | Kiritsy Christopher P | Director | Grant(A) | 40K | — | $0 |
| Jun 22, 2022 | Richman Michael | Director | Grant(A) | 40K | — | $0 |
| Jun 22, 2022 | Sherman Matthew L | Director | Grant(A) | 40K | — | $0 |
| May 13, 2022 | Demuth Tim | Chief Medical Officer | Buy(P) | 6K | $1.71 | $10K |
| Feb 22, 2022 | Demuth Tim | Chief Medical Officer | Grant(A) | 100K | — | $0 |
| Feb 22, 2022 | Mousa Ahmed | Chief Business Officer | Grant(A) | 216K | — | $0 |
| Feb 22, 2022 | Olwill Shane | Chief Development Officer | Grant(A) | 216K | — | $0 |
| Feb 22, 2022 | Bures Thomas | Chief Financial Officer | Grant(A) | 216K | — | $0 |
| Feb 22, 2022 | Kaufmann Hitto | SVP, Chief Scientific Officer | Grant(A) | 216K | — | $0 |
| Feb 22, 2022 | Yoder Stephen S. | Chief Executive Officer, Director | Grant(A) | 626K | — | $0 |
| Aug 30, 2021 | Olwill Shane | Chief Development Officer | Option exercise(M) | 38K | — | $0 |
| Aug 30, 2021 | Olwill Shane | Chief Development Officer | Sell(S) | 9K | $5.00 | $46K |
| Aug 30, 2021 | Olwill Shane | Chief Development Officer | Sell(S) | 29K | $5.15 | $150K |
| Aug 30, 2021 | Olwill Shane | Chief Development Officer | Option exercise(M) | 38K | $1.52 | $58K |
| Aug 1, 2021 | Demuth Tim | Chief Medical Officer | Grant(A) | 360K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).